Introduction
============

*Pseudomonas aeruginosa* is a Gram-negative human pathogen that can be isolated from most environments, including soil, marshes, coastal marine habitats, plants, and mammal tissue ([@B4]). It is an opportunistic human pathogen that causes infections of the pulmonary tract, urinary tract, and burn wounds ([@B2]). Its ability to form biofilms is thought to contribute to the persistence of *P. aeruginosa* in lung infections ([@B39]). Biofilms are a matrix-enclosed, surface-associated, multi-cellular assemblages that protect cells in hostile environments ([@B13]) such as phagocytosis ([@B16]). Biofilms are formed through the production of extracellular matrix composed of water, exopolysaccharides (EPS), nucleic acids, proteins, and lipids ([@B11]).

*Pseudomonas aeruginosa* is one of the most-studied microbes with respect to the genetic regulation taking place throughout the process of biofilm formation ([@B33]; [@B26]); however, this regulation is not completely elucidated. For example, the genetic mechanism for matrix formation has not been fully elucidated ([@B12]), and the complex role of the matrix is only beginning to be understood; for example, the interaction between the Pel polymer and extracellular DNA in *P. aeruginosa* ([@B19]). The molecular mechanisms that regulate biofilm formation differ between strains, while some features are conserved in biofilm formation such as the formation of extracellular matrix ([@B23]). The formation and maintenance of *P. aeruginosa* PA14 (henceforth PA14) biofilm critically depends upon the production of two distinct EPS, alginate and Pel ([@B13]). Pel is a polymer of *N*-acetyl-β-[D]{.smallcaps}-glucosamine (GlcNAc) and *N*-acetyl-β-[D]{.smallcaps}-galactosamine (GalNAc) ([@B19]), and *pel* mutations dramatically decrease biofilm formation as well as the pellicle that forms at the air-liquid interface ([@B13]). The regulation of the *pel* operon involves tyrosine phosphatase TpbA ([@B49]) and the Las quorum sensing system ([@B40]).

In many Gram-negative bacteria, ATP binding cassette (ABC) transporters are used to transport substrates across the inner and outer membrane ([@B5]) using the energy derived from the hydrolysis of ATP ([@B30]). Transport systems including ABC transporters often recognize diverse substrates, such as ions, amino acids, and antibiotics ([@B30]), as well as materials required for biofilm formation ([@B31]; [@B18]). In *P. aeruginosa*, ABC transport system DppBCDF is responsible for the uptake of dipeptides and tripeptides, which are used as nitrogen sources. The specificity of DppBCDF is controlled by its 5 substrate-binding proteins (SBPs) DppA1-A5 (PA14_58350, PA14_58360, PA14_58390, PA14_58420, and PA14_70200 in *P. aeruginosa* PA14, respectively), which function in the periplasmic space ([@B34]). ABC transporters function in DNA replication, protein degradation, membrane fusion, antibiotic efflux, signal transduction, and chemotaxis ([@B25]).

Filamentous bacteriophage such as f1, fd, and M13 of *Escherichia coli* are lysogens that, upon excision, are packaged as single-stranded phages that have a long filamentous shape; in *Pseudomonas* spp. they are designated as Pf phage (Pf1 to Pf6) ([@B25]). PA14 contains only Pf5 which is most closely related to Pf4 of *P. aeruginosa* PAO1 (63% homology) and somewhat related to Pf1 ([@B29]). Specifically, Pf5 of PA14 is missing five genes of Pf4 of PAO1 (PA0715, PA0716, PA0728, and PA0729), and has three additional genes (PA14_49030, PA14_49010, and PA14\_ 49020) ([@B29]). Pf5 is thought not lead to phage particles ([@B29]).

In *P. aeruginosa* biofilms, Pf1-related genes are highly expressed (up to 84-fold) suggesting that phage induction might be important for gene transfer within biofilms ([@B53]) and may be important as a stress response ([@B17]). Furthermore, there is a repeatable pattern of cell death and lysis in biofilms ([@B52]). Subsequently, Pf4 prophage were found to be essential for autolysis (programmed cell death) in *P. aeruginosa* PAO1 as deletion of the prophage prevented cells from undergoing cell death and from developing hollow regions in biofilms ([@B38]). Filamentous phage may also be secreted by the host without lysis ([@B17]). In *P. aeruginosa*, filamentous phage may also lead to the emergence of small-colony variants that might function in multicellular biofilm development ([@B51]). However, others have found that the prophage of PA14 and many clinical isolates do not affect small-colony variants which arise in biofilms ([@B29]). In addition, Pf4 prophage facilitate biofilm formation by promoting the formation of liquid crystals of phage and *P. aeruginosa* PAO1 matrix polymers ([@B42]). Hence, filamentous bacteriophage are important for *P. aeruginosa* biofilm formation and may be involved in the production of small-colony variants.

Our goal here was to characterize the manner in which the SBP DppA1 (PA14_58350 in PA14 and PA4496 in *P. aeruginosa* PAO1), promotes biofilm formation in *P. aeruginosa;* this protein was identified via screen of 5850 transposon mutants that affected biofilm formation ([@B49]). We found that inactivation of *dppA1* abolished biofilm formation in flow devices and delayed swarming. Using a whole-transcriptome analysis, we also determined that deletion of *dppA1* induced bacteriophage Pf5 genes during biofilm formation and led to a million-fold increase in lytic phage particles. Hence, DppA1 regulates Pf5 prophage to reduce biofilm formation.

Materials and Methods {#s1}
=====================

Bacterial Strains, Plasmids, Primers, and Growth Conditions
-----------------------------------------------------------

Strains and plasmids used in this study are listed in **Table [1](#T1){ref-type="table"}**. PA14 and its isogenic mutants were obtained from the Harvard Medical School ([@B22]). Transposon insertion of the *dppA1* mutant was verified using a two-round PCR protocol^[1](#fn01){ref-type="fn"}^. Briefly, a PCR product was amplified from chromosomal DNA using primer pair GB 3a and Arb1D (**Table [2](#T2){ref-type="table"}**); the product of this reaction was used as a template for the second reaction with primer pair GB 2a and Arb2A which was sequenced with two primers GB 2a and GB 4a (**Table [2](#T2){ref-type="table"}**). The transposon insertions in *dppA2, dppA3, dppA4, dppA5*, and *dppC* were verified using flanking PCR with primer pairs Gb 4a/dppA2 R, Gb 4a/dppA3 R, dppA4 F/dppA4 R, Gb 4a/dppA5 R, and Gb 4a/dppC R, **Table [2](#T2){ref-type="table"}**). *P. aeruginosa* and *E. coli* were routinely grown in Luria--Bertani (LB) medium at 37°C with aeration (250 rpm). Gentamicin (15 μg/mL) was used for growth of the *P. aeruginosa* transposon mutants, and carbenicillin (300 μg/mL) was used to maintain pMQ70 vector ([@B43]). The specific growth rate was calculated using turbidity at 600 nm from 0.05 to 0.7.

###### 

Strains and plasmids used in this study.

  Strain and plasmids            Genotype or description                                                    Reference
  ------------------------------ -------------------------------------------------------------------------- ------------
  ***P. aeruginosa***                                                                                       
  PA14                           Wild-type strain                                                           [@B22]
  PA14_58350 (PA4496, *dppA1*)   PA14_58350 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_58360 (PA4497, *dppA2*)   PA14_58360 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_58390 (PA4500, *dppA3*)   PA14_58390 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_58420 (PA4502, *dppA4*)   PA14_58420 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_70200 (PA5317, *dppA5*)   PA14_70200 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_58450 (PA4504, *dppC*)    PA14_58450 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_13660 (PA3885, *tpbA*)    PA14_13660 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_24480 (PA3064, *pelA*)    PA14_24480 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_19120 (PA3477, *rhlR*)    PA14_19120 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_33700 (PA2396, *pvdF*)    PA14_33700 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_49000 (PA0717)            PA14_49000 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_48990 (PA0718)            PA14_48990 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_48970 (PA0720)            PA14_48970 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_48940 (PA0723)            PA14_48940 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_48920 (PA0725)            PA14_48920 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  PA14_48890 (PA0727)            PA14_48890 Ω *Mar2xT7*, Gm^R^                                              [@B22]
  ***E. coli***                                                                                             
  HB101/pRK2013                  *pro leu thi lacY Str^R^ endol^-^ recA^-^ r^-^ m^-^* with pRK2013, Km^R^   [@B49]
  TG1                            *K12, lac--pro supE thi hsdD5 (F' traD36 proA^+^B^+^ lacI^q^ lacZ M15*     [@B49]
  **Plasmids**                                                                                              
  pMQ70                          Car^R^, Ap^R^, P~BAD~, expression vector                                   [@B43]
  pMQ-*dppA1*                    Car^R^, Ap^R^, P~BAD~:: *dppA1*, complementation vector                    This study

Gm

R

and Car

R

indicate gentamicin, and carbenicillin resistance, respectively.

###### 

Primers used for DNA sequencing, complementation, phage excision, and quantitative real-time, reverse-transcription PCR (qRT-PCR) in this study.

  Primer name          Primer sequence (listed 5′--3′)
  -------------------- -------------------------------------------------------------
  **DNA sequencing**   
  GB 2a                TGTCAACTGGGTTCGTGCCTTCATCCG
  GB 3a                TACAGTTTACGAACCGAACAGGC
  GB 4a                GACCGAGATAGGGTTGAGTG
  Arb1D                GGCCAGGCCTGCAGATGATGNNNNNNNNNNGTAT
  Arb2A                GGCCAGGCCTGCAGATGATG
  dppA2 R              ATCTGCTCGTGGAAGATTCG
  dppA3 R              GTAGCGGCTCAGGATGAAAG
  dppA4 F              AACCTCGCTCTGGACAAGAA
  dppA4 R              AACGGATTGATCACGTAGCC
  dppA5 R              CAGATGTTCAGCTCGGGAAG
  dppC R               CATCAGGTTGATCGCCAGTA
  **Complementaion**   
  DppA1-OE1            GCCCCCGCTAGCAAGAAGGAGATATACCATGCGTAGAAACGCCGTCATCCGC
  DppA1-OE2            GCCCCCAAGCTTCTAGTGGTGGTGGTGGTGGTGCTTGCCGACGCTGACCTCGTAGAACG
  **Page excision**    
  Pf5-F                CAGGTAGAGCAGGATGTCG
  Pf5-R                GCGTTGAACAGGAGGAAATGG
  Pf5RF-F              AACAGTGAATTGCGGACAAGG
  Pf5RF-R              ACGGTGGAAACATCCTGGC
  Pf5-q-F2             GGTGCTCTGGAATCCGGGTGTTC
  Pf5-q-R2             GTGGTCGAGGTCGGGAGTCATGG
  rplU-F               AGGTTACCGCTGAAGTGGTTT
  rplU-R               CCGGTGATCTTGATTTCAGTG
  **qRT-PCR**          
  PA0718-RT1           AGTCCCTACTACCTGCACCAAAC
  PA0718-RT2           CGTACACAACGTGCCAGTACTTC
  PA0722-RT1           CAACAGGCCTACCTGATTCC
  PA0722-RT2           GGCTTTACGAAGAAGTGACG

Complementation of *dppA1*
--------------------------

To complement the *dppA1* mutation, DppA1 was produced using the pBAD promoter in pMQ70 ([@B43]). *dppA1* was amplified using Pfu DNA polymerase with primers DppA1-OE1 and DppA1-OE2 (**Table [2](#T2){ref-type="table"}**). The PCR product was cloned into the *Nhe*I and *Hind*III cloning sites of pMQ70, creating pMQ-*dppA1*. The plasmid was confirmed by sequencing and transformed by conjugation ([@B49]) using helper strain HB101/pRK2013.

Biofilm Assay
-------------

Biofilm formation was examined in quiescent cultures using 96-well polystyrene plates and crystal violet staining ([@B49]). Overnight-grown cultures of *P. aeruginosa* were diluted to a turbidity of 0.05 at 600 nm with fresh LB medium, then 300 μL of diluted bacterial culture were incubated in 96-well polystyrene plates for 4, 8, and 24 h. Six wells were used for each strain, and two independent cultures were used for each experiment. The *tpbA* and *pelA* mutants were used as a positive control and a negative control, respectively ([@B49]).

Biofilm formation in flow cells was examined by diluting overnight cultures to a turbidity of 0.05 in 5% LB medium and pumping this culture through the flow-cell (BST model FC81, Biosurface Technologies, Bozeman, MT, United States) at 10 mL/h for 2 h ([@B50]). Fresh 5% LB medium was added for 72 h, then the biofilms were stained with SYTO9 dye (5 μL/mL) for 20 min and were visualized using a TCS SP5 scanning confocal laser microscope (Leica Microsystems, Wetzlar, Germany). Nine random positions were chosen, and 25 images were taken for each position. Simulated three-dimensional images were obtained using IMARIS software (BITplane, Zurich, Switzerland), and the biomass, surface coverage, mean thickness, and roughness coefficient were determined using COMSTAT image-processing software ([@B15]).

Small-Colony Variants
---------------------

Small-colony variants were examined as described previously ([@B29]). Approximately 2.5 × 10^8^ bacteria from overnight cultures were inoculated into glass tubes containing 5 mL of fresh LB medium and were incubated under static conditions for 2 to 5 days. Cells were removed from the tubes vortexed vigorously followed by gentle sonication (3W, 15 s) of 1 mL samples to dissolve bacterial aggregates completely. The sonicated cultures were diluted with PBS and plated on Congo-Red agar plates, which were incubated for 24 h. Two independent cultures were used for each strain along with three replicates for each culture.

Prophage Excision
-----------------

Excision was detected by PCR and by qPCR. Total DNA was extracted using the Ultra Clean Microbial DNA Isolation Kit (MO BIO Laboratories, Inc., Carlsbad, CA, United States). For the PCR method, excision was detected by amplifying the PA14 genome using primers PF5-F and PF5-R (these primers only give a band when the prophage has excised) (**Table [2](#T2){ref-type="table"}**) and by amplifying circular prophage using primers PF5RF-F and PF5RF-R (these primers only give a band when the prophage has circularized) (**Table [2](#T2){ref-type="table"}** and Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). For the qPCR method, total DNA (80 ng) was used with the PF5-q-F2 and PF5-q-R2 primers (**Table [2](#T2){ref-type="table"}**) and the ABI Power SYBR^®^ Green RNA-to-CT^TM^ 1-Step Kit (Applied Biosystems, Carlsbad, CA, United States); these results were confirmed by using the Step OnePlus^TM^ Real-Time PCR System (Applied Biosystems, Foster City, CA, United States). Two independent cultures were used for each strain along with four replicates for each culture.

Plaque Assay
------------

The plaques were quantified by using a modified top-layer agar approach ([@B9]). The bacterial lawns of the wild-type PA14 were prepared using early exponential-phase cells (10^8^ cells/mL) in LB media. For the phage stock solution, PA14 and the *dppA1* mutant were washed with fresh LB media (to remove any phage), inoculated (1%) into 25 mL of fresh LB media, and incubated with shaking for 8 h. Supernatants from the PA14 and the *dppA1* mutant were harvested by centrifugation (7,000 rpm for 15 min), diluted from 1/10^0^ to 1/10^4^, and mixed with 0.1 mL of wild-type bacteria (10^8^ cells/mL) in 4 mL of soft agar. The soft agar was poured onto the agar surface of a warm base plate. Plaques were observed after incubating for 6, 12, and 24 h. This plaque assay was performed with six independent cultures for each strain with three replicates for each culture.

Live/Dead Assay
---------------

The percentage of live cells were determined using the LIVE/DEAD BacLight Bacterial Viability Kits L7012 (Molecular Probes, Inc., Eugene, OR, United States). The samples were harvested at the same turbidity at 600 nm after 3 to 5 h. The fluorescence emission spectrum (excitation 470 nm, emission 490 to 700 nm) of each cell suspension was measured using an Infinite M200 Pro plate reader (Tecan, Switzerland). The ratio was calculated of the integrated intensity of the portion of each spectrum from 510 to 540 nm (green, live cells) to that from 620 to 650 nm (red, dead cells) for each bacterial suspension. Isopropanol-treated cells (30 min) were used as the dead cell negative control.

Motility Assay
--------------

Swarming motility was examined with BM-2 plates (62 mM potassium phosphate, 2 mM MgSO4, 10 mM FeSO4, 0.1% Casamino acids, 0.4% glucose, and 0.5% Bacto agar) ([@B32]) after growth for 8 and 16 h. Three plates were tested for each culture, and two independent cultures were used. The *rhlR* mutant was used as a negative control ([@B20]).

EPS Assay
---------

Exopolysaccharides production was quantified via Congo red staining ([@B24]). One mL of overnight-grown culture was washed with 1 mL of 1% tryptone (T-broth), resuspended in 1 mL T-broth, and sonicated three times at 3 W for 10 s. Bacterial suspensions in T-broth (500 μL) were incubated with 40 μg/mL Congo red with vigorous shaking (250 rpm) for 2 h. At that time, the absorbance of the supernatants was measured at 490 nm using a spectrophotometer. The *tpbA* and *pelA* mutants were used as positive control and negative controls, respectively ([@B49]).

Pyoverdine Assay
----------------

Production of pyoverdine was determined as described previously ([@B37]). Overnight cultures in LB broth were diluted to a turbidity of 0.05 at 600 nm in 25 mL of minimal succinate medium (6 g/L K~2~HPO~4~, 3 g/L KH~2~PO~4~, 1 g/L (NH~4~)~2~SO~4~, 0.2 g/L MgSO~4~⋅7H~2~O, and 9.15 g/L sodium succinate), and were incubated with aeration (250 rpm) for 4, 6, and 8 h. The absorbance at 405 nm of the supernatants was used for quantifying pyoverdine production which was normalized by cell turbidity.

Pyocyanin Assay
---------------

Production of pyocyanin was quantified by the absorbance at 520 nm in acidic solution ([@B10]) and was normalized by cell turbidity. A 800 μL sample of culture grown in LB broth for 24 h was extracted with 480 μL of chloroform and then re-extracted into 800 μL of 0.2 N HCl to give a pink to deep red solution.

Whole-Transcriptome Analysis
----------------------------

The *P. aeruginosa* genome array (Affymetrix, P/N 510596) was used to investigate differential gene expression in biofilm cells between wild-type PA14 and the *dppA1* mutant. After incubating in 250 mL LB medium with 10 g of glass wool for 7 h with aeration (250 rpm), biofilm cells were harvested from the glass wool, and the cell pellets were resuspended in RNA*later* (Ambion Inc., Austin, TX). Total RNA was isolated using the RNeasy Mini Kit (Qiagen Inc., Valencia, CA, United States) ([@B35]) and a bead beater (Biospec, Bartlesville, OK, United States). cDNA synthesis, fragmentation, and hybridizations were performed as described previously ([@B14]). If the gene with the larger transcription rate did not have a consistent transcription rate based on the 13 probe pairs (*p*-value less than 0.05), these genes were discarded. A gene was considered differentially expressed when the *p*-value for comparing two chips was lower than 0.05 (to assure that the change in gene expression was statistically significant and that false positives arise less than 5%) and if their fold change is higher than standard deviation for the whole genome ([@B36]) (1.8-fold). The expression data have been submitted to the NCBI Gene Expression Omnibus (GSE24638). The STRING online database was used to construct a protein-protein interaction network among the proteins ([@B45]).

Quantitative Real Time, Reverse Transcription-PCR (qRT-PCR)
-----------------------------------------------------------

Quantitative real time, reverse transcription-PCR was performed using the StepOnePlus^TM^ Real-Time PCR System (Applied Biosystems, Foster City, CA, United States). Expression levels were measured using total RNA isolated from biofilm cells under the same conditions as the microarray experiment (independent samples were used). The primers for qRT-PCR are listed in **Table [2](#T2){ref-type="table"}**. The values were normalized using a housekeeping gene *rplU* ([@B21]).

Results
=======

DppA1 Increases Biofilm Formation
---------------------------------

Previously, by screening 5850 transposon mutants for altered biofilm formation, we identified 137 transposon mutants with over threefold enhanced biofilm formation and 88 transposon mutants with 10-fold reduced biofilm formation ([@B48]). Among these, inactivating *dppA1* decreased biofilm formation by 68-fold after 24 h in LB medium in quiescent 96-well plates (**Figure [1A](#F1){ref-type="fig"}**). In comparison, the isogenic positive control, *tpbA*, increased biofilm eightfold, and the negative control, *pelA*, decreased biofilm ninefold. The decreased biofilm formation by inactivating *dppA1* was restored by complementing with plasmid PMQ-*dppA1* (**Figure [1A](#F1){ref-type="fig"}**). Hence, DppA1 increases biofilm formation in PA14.

![*dppA1* decreases biofilm formation. **(A)** Total biofilm formation (at the liquid/solid and air/liquid interfaces) in polystyrene plates at 37°C in LB after 24 h. Six wells were used for each independent culture, and the averages of two independent experiments ±SD are shown. **(B)** Biofilm formation in flow cells with 5% LB after 72 h. Images were produced by IMARIS, and representative images are shown. Asterisks above the columns represent significance based on the unpaired Wilcoxon *t*-test (^∗∗∗∗^*p* \< 0.0001).](fmicb-09-00030-g001){#F1}

To verify these static biofilm formation results from 96-well plates, we investigated biofilm formation in flow cells. Critically, the *dppA1* mutant had no biofilm formation in the flow-cell under these conditions while the wild-type PA14 strain formed a robust biofilm (**Figure [1B](#F1){ref-type="fig"}**). These results were quantified using COMSTAT statistical analysis which showed 0% biomass, 0% mean thickness, and 0.14% surface coverage at 72 h for the *dppA1* mutant (**Table [3](#T3){ref-type="table"}**). These results confirmed that DppA1 positively influences biofilm formation in both static and flow conditions.

###### 

COMSTAT analysis for biofilms of PA14 and the *dppA1* mutant in flow cells.

  COMSTAT values          PA14        *dppA1*
  ----------------------- ----------- -------------
  Biomass (μm^3^/μm^2^)   7 ± 4       0 ± 0
  Surface coverage (%)    7 ± 4       0.14 ± 0.02
  Mean thickness (μm)     14 ± 9      0 ± 0
  Roughness coefficient   1.4 ± 0.2   2 ± 0

Biofilms were evaluated after 72 h of development in 5% LB medium at 37°C.

We also investigated whether the effect on biofilm formation was specific for DppA1 since there are four other substrate binding proteins for dipeptides associated with ABC transporter DppBCDF. We found that the mutations in the other substrate binding protein *dppA2, dppA3, dppA4*, and *dppA5* have no effect on biofilm formation, i.e., these mutants have the same biofilm level as the wild-type strain. Furthermore, we found that there was no effect on biofilm formation upon mutating the permease DppC. Therefore, the dramatic biofilm reduction phenotype is specific for inactivating DppA1.

Small-Colony Variants
---------------------

Since DppA1 increases biofilm formation dramatically, we also investigated whether DppA1 increases the formation of small-colony variants. Inactivating *dppA1* reduces the production of small-colony variants by 20-fold (40% for wild-type vs. 2% for the *dppA1* mutant, images of colonies not shown). Production of DppA1 from pMQ-*dppA1* increased the number of small-colony variants to about half that of the wild-type strain; hence, the large decrease in small-colony variants could be partially complemented.

DppA1 Increases Swarming
------------------------

Since *dppA1* encodes a putative binding protein component of an ABC transporter, and many transport genes control swarming motility in *P. aeruginosa* (e.g., PA14_48280, PA14_40620, PA14_30660, PA14_20110, and PA14_16890) ([@B54]), we examined swarming motility for *dppA1* and found that this mutation abolished swarming in the first 8 h; this phenotype could be complemented by expressing *dppA1* in trans (**Figure [2A](#F2){ref-type="fig"}**). An *rhlR* mutant was used a negative control for swarming ([@B20]). Critically, swarming resumed for the *dppA1* mutant after an additional 8 h. These results suggest a small percentage of cells recovered after some event to give the wild-type swarming phenotype.

![*dppA1* decreases swarming and pyoverdine production and decreases exopolysaccharides (EPS). **(A)** Swarming motility at 37°C after 15 h. **(B)** Pyoverdine production after 4, 6, and 8 h. **(C)** EPS production of PA14 strains after 24 h at 37°C. The averages of two independent experiments ±SD are shown.](fmicb-09-00030-g002){#F2}

DppA1 Decreases EPS Production
------------------------------

Given the large reduction in biofilm formation upon inactivating DppA1, the biofilm-associated factors in PA14, including EPS, pyocyanin, and pyoverdine were assessed in the *dppA1* mutant. Since Congo red (CR) binds extracellular matrix components including EPS in many bacteria ([@B13]), EPS was assayed through Congo red staining with the PA14 and the *dppA1* mutant. Surprisingly, the *dppA1* mutant produced 85-fold more EPS than wild-type PA14 (**Figure [2C](#F2){ref-type="fig"}**). For these EPS experiments, the *pelA* mutant was used as a negative control, and the *tpbA* mutant was used as a positive control ([@B49]).

Moreover, since pyocyanin is a redox-active pigment secreted by *P. aeruginosa* that affects the structure of biofilms ([@B6]), and iron serves as a signal in *P. aeruginosa* biofilm development through pyoverdine iron acquisition ([@B3]), we investigated whether pyocyanin and pyoverdine production is altered by in the *dppA1* mutant. The *phzM/phzS* ([@B27]) and *pvdF* mutants ([@B3]) were used as negative controls for pyocyanin and pyoverdine production, respectively. We found there was no difference in pyocyanin production between PA14 and the *dppA1* mutant LB medium at 10 h and 24 h (data not shown), while the *dppA1* mutant decreased pyoverdine production twofold compared to PA14 at 8 h (**Figure [2B](#F2){ref-type="fig"}**).

DppA1 Represses Bacteriophage Pf5 in Biofilm Cells
--------------------------------------------------

To determine how the *dppA1* mutation affects biofilm formation, a whole-transcriptome analysis was performed to compare gene expression in early biofilm formation (7 h) for the *dppA1* mutant relative to the wild-type (grown on glass wool). Surprisingly, since *dppA1* is not near the Pf5 locus, the whole-transcriptome data showed that inactivation of *dppA1* significantly induced 10 bacteriophage Pf5 genes (**Table [4](#T4){ref-type="table"}**). To confirm the induction of the prophage Pf5 genes, expression of PA0718 and PA0722 were determined by qRT-PCR. Using total RNA isolated from biofilm cells of PA14 and *dppA1*, we found that PA0718 and PA0722 were induced 30 ± 4-fold and 41 ± 4-fold in the *dppA1* mutant compared to PA14, respectively.

###### 

Summary of the differentially expressed biofilm genes related to bacteriophage Pf5 for the *dppA1* mutant vs. wild-type PA14 in LB medium for 7 h at 37°C.

  PAO1 ID   PA14 ID      Gene name   Fold change   Description
  --------- ------------ ----------- ------------- ---------------------------------
  PA0717    PA14_49000               7.0           Hypothetical protein
  PA0718    PA14_48990               12.1          Hypothetical protein
  PA0719    PA14_48980               7.5           Hypothetical protein
  PA0720    PA14_48970               6.5           Single-stranded binding protein
  PA0721    PA14_48960               10.6          ABC transporter permease
  PA0722    PA14_48950               9.2           Hypothetical protein
  PA0723    PA14_48940   *coaB*      2.8           Coat protein B
  PA0725    PA14_48920               5.7           Head virion protein G6P
  PA0726    PA14_48910   *zot*       3.2           Zona occludens toxin
  PA0727    PA14_48890               2.1           Hypothetical protein

Raw data for the two DNA microarrays are available using GEO series accession number

GSE24638

.

Based on these results; i.e., that inactivation of *dppA1* induced bacteriophage Pf5 and reduced biofilm formation, we hypothesized that deletion of individual bacteriophage Pf5 genes should increase biofilm formation. In agreement with this hypothesis, we found that the PA0723 and PA0725 mutants exhibited 4 ± 1- and 3 ± 1-fold increase in biofilm formation in LB medium at 4 h, respectively (**Figure [3](#F3){ref-type="fig"}**). Therefore, *dppA1* represses, either directly or indirectly, expression of Pf5 genes which results in increased biofilm.

![*dppA1* influences biofilm formation through bacteriophage Pf5. Relative biofilm formation in polystyrene plates at 37°C in LB after 4 and 8 h due to inactivating bacteriophage Pf5 genes. Six wells were used for each culture. The averages of two independent experiments ±SD are shown. Asterisks above the columns represent significance based on the unpaired Wilcoxon *t*-test relative to PA14 for each time (^∗∗∗∗^*p* \< 0.0001, ^∗∗∗^*p* \< 0.001, ^∗∗^*p* \< 0.01, and ^∗^*p* \< 0.05).](fmicb-09-00030-g003){#F3}

DppA1 Decreases Pf5 Excision
----------------------------

Since the *dppA1* deletion increases transcription of the Pf5 phage locus, we checked for prophage excision in this strain relative to the wild-type strain by quantifying the presence of re-circularized prophage via PCR for a pair of primers that only give a PCR band if the circularized prophage is formed (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). As expected, we found via PCR that the *dppA1* deletion led to a 10-fold increase in excised, circularized prophage compared to the wild-type strain as well as a corresponding 10-fold increase in the chromosomal deletion area.

To corroborate and better quantify these PCR results, we performed qPCR with *rplU* as the housekeeping gene and found that the *dppA1* deletion had 600 ± 1-fold greater Pf5 phage excision from the chromosome compared to the wild-type strain (0.1% vs. 0.00017%) (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Hence, DppA1 either directly or indirectly represses phage excision in the wild-type strain.

DppA1 Decreases Plaque Formation, Increases Growth, and Reduces Cell Lysis
--------------------------------------------------------------------------

The induction of Pf5 phage genes, the increased Pf5 excision, the increase in EPS, and the delay in swarming motility, all suggest that inactivating DppA1 results in active cell lysis. Hence, we measured plaque formation with the supernatants of the *dppA1* mutant and wild-type and found an explosive 1.7 million-fold increase in plaque formation when DppA1 is inactivated (1.5 ± 0.3 × 10^8^ vs. 0.9 ± 0.5 × 10^2^ pfu/mL) after growth for 8 h in rich medium (turbidity around 3). Note that we used the wild-type strain as is routinely done ([@B17]) to enumerate the number of Pf5 phage that are capable of superinfection; these superinfective phage arise rapidly ([@B38]); hence, the large change in phage found is for the superinfecting form of Pf5.

Corroborating the results showing extraordinary phage production, growth of the *dppA1* mutant is initially dramatically slower than the wild-type due to phage lysis (**Figure [4](#F4){ref-type="fig"}**). This slow-growth phenotype was completely complemented by producing DppA1 from plasmid pMQ-*dppA1.*

![*dppA1* decreases growth. Cells were grown in LB broth at 37°C with shaking. The averages of two independent experiments ±SD are shown.](fmicb-09-00030-g004){#F4}

We reasoned that the increase in plaque production should lead to an increase in lysis. Confirming this, total protein increased twofold in the supernatants of the *dppA1* mutant vs. the wild-type strain. In addition, cell death was confirmed via Live/Dead staining where all of the wild-strain were alive after 5 h but 50% of the *dppA1* mutant were dead (isopropanol-treated cells were used as the dead cell negative control) (Supplementary Table [S2](#SM1){ref-type="supplementary-material"}).

DppA1 Is a Substrate-Binding Protein
------------------------------------

To provide insights into how DppA1 regulates biofilm formation and phage excision, we performed a protein domain analysis using the Conserved Domain Search Service^[2](#fn02){ref-type="fn"}^ and Basic Local Alignment Search Tool^[3](#fn03){ref-type="fn"}^ from NCBI, which showed that DppA1 (537 aa, PA14_58350 in *P. aeruginosa* PA14 and PA4496 in *P. aeruginosa* PAO1) contains a domain belonging to substrate-binding component of an ABC-type dipeptide import system PBP2 (PBP2_DppA_like, NCBI conserved domains accession no. cd08493). DppA1 has been shown to transport 72 of 246 tested dipeptides and 3 of 14 tripeptides tested ([@B34]). The PBP2 family members bind dipeptides and some tripeptides and are involved in chemotaxis toward dipeptides. The PBP2 superfamily also includes the ligand-binding domains from ionotropic glutamate receptors, LysR-type transcriptional regulators ([@B1]), and unorthodox sensor proteins involved in signal transduction ([@B46]). Hence, there is precedent for SBPs such as DppA1 acting as regulators. However, DppA1does not contain any DNA/RNA binding domains.

To confirm the role of DppA1 as a dipeptide binding protein, we measured growth of the *dppA1* mutant on the dipeptides Phe-Pro and Gly-Glu as the sole carbon and energy sources. In contrast to the wildtype, the *dppA1* mutant cannot grow on these two dipeptides (Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). As a negative control, the wild-type could not grow on M9 buffer that lacks a carbon source, and as a positive control, the unrelated PA4499 mutation did not affect growth on dipeptides. Hence, DppA1 is a *bona fide* dipeptide binding protein involved in their transportation.

Since Pf5 in *P. aeruginosa* PA14 lacks a few proteins of Pf4 found in *P. aeruginosa* PAO1, we hypothesized that DppA1 may be related to PA0716, which is also a component of an ABC transporter of Pf4 in *P. aeruginosa* PAO1 (441 aa); PA0176 contains an ATP-binding cassette domain of nickel/oligopeptides specific transporters (ABC_NikE_OppD_transporters, NCBI conserved domains accession no. cd03257), and also seems to be a putative AbiEii toxin of type IV toxin/antitoxin systems ([@B8]). However, DppA1 and PA0716 belong to different ABC transporter families, and the amino acid identity between DppA1 and PA0716 is only 7%.

Discussion
==========

Many studies have shown that bacteriophage are important in biofilm development in both Gram-positive ([@B44]) and Gram-negative bacteria ([@B53]; [@B7]), especially under conditions where the cells are stressed, such as those that exist in biofilms ([@B7]). Cell death and lysis occur in biofilms, and biofilm killing is related to filamentous phage ([@B52]). Furthermore, the emergence of small-colony variants and biofilm development is related to phage ([@B51]). Here we found that SBP DppA1 helps facilitate the growth on dipeptides and increases PA14 biofilm formation 68-fold. Critically, we determined that the mechanism by which DppA1 increases biofilm formation: DppA1 directly or indirectly represses Pf5 prophage genes which prevents cell lysis and a million-fold production of active phage.

Although the importance of Pf phage in *P. aeruginosa* biofilm formation is well-documented, such as the formation of extracellular liquid crystals by Pf4 with alginate and extracellular DNA ([@B42]) and the hyper-mutability of Pf4 during biofilm evolution ([@B28]), our results shed light on how this phage is regulated, through the unexpected mechanism of a SBP DppA1. Clearly DppA1 helps to limit phage lysis and thereby increases biofilm production by reducing excess phage production; this appears to be at least part of the unknown mechanism by which Pf phage generate diversity in biofilms that was alluded to previously ([@B17]).

Furthermore, the mechanism we found here for DppA1 for controlling phage production and biofilm formation is distinct. For example, in contrast to our results where excessive phage production is deleterious for biofilm formation, previous work has shown that explosive cell lysis via an endolysin from cryptic prophage is beneficial for biofilm formation since it produces extracellular DNA that helps to initiate biofilm production ([@B47]). Therefore, phage production and phage-related genes must be regulated well to control biofilm formation.

Further work is clearly required to determine the mechanism by which DppA1 represses Pf5 prophage genes, either directly or indirectly, through dipeptide transport. However, it is tempting to speculate that the dipeptides transported by DppA1 in the periplasm are relayed as a signal to the Pf5 phage integrase/excisionase (PA14_48880) or some other phage regulator to limit phage lysis when nutrients are plentiful (extracellular proteins are readily degraded by the extracellular proteases of PA14). In contrast, when nutrients are depleted, the dipeptides transported by DppA1 are reduced, and Pf5 phage are produced to drive cell evolution and to create voids in biofilms to facilitate dispersal (inactivation of *dppA1* would mimic a no peptide condition). Such biofilm voids and dispersal have been shown to be dependent on the related phage, Pf4 ([@B38]), and biofilm dispersal has long been known to be governed by changes in nutrient levels ([@B41]). Therefore, the dipeptide concentrations in the cells, governed by DppA1 transport, may serve as a simple indicator of external nutrient levels and control biofilm development.
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